tiprankstipranks
Anavex Life Sciences (AVXL)
NASDAQ:AVXL
US Market

Anavex Life Sciences (AVXL) Income Statement

Compare
1,578 Followers

Anavex Life Sciences Income Statement

Last quarter (Q4 2024), Anavex Life Sciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Anavex Life Sciences's net income was $-11.62M. See Anavex Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 24Sep 23Sep 22Sep 21Sep 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 52.88M$ 55.76M$ 50.99M$ 41.95M$ 30.94M
Depreciation and Amortization
$ 0.00$ -2.72M$ -3.32M$ 37.45M$ 26.71M
EBITDA
$ 0.00$ -55.76M$ -50.94M$ 0.00$ 0.00
Operating Income
$ 0.00$ -55.76M$ -54.40M$ -41.92M$ -30.76M
Other Income/Expenses
$ 0.00$ 8.26M$ 3.37M$ 4.36M$ 4.83M
Pretax Income
$ -43.00M$ -47.50M$ -47.62M$ -37.64M$ -26.26M
Net Income
$ -43.00M$ -47.51M$ -47.98M$ -37.91M$ -26.28M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.52$ -0.60$ -0.62$ -0.54$ -0.45
Diluted EPS
$ -0.52$ -0.60$ -0.62$ -0.54$ -0.45
Weighted Average Shares Outstanding
83.47M 79.79M 76.91M 69.80M 58.19M
Weighted Average Shares Outstanding (Diluted)
83.47M 79.79M 76.91M 69.80M 58.19M
Currency in USD

Anavex Life Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis